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Background: Peripheral arterial disease (PAD) presenting as intermittent claudication (IC) is routinely assessed as the
distance or time walked to the onset of pain, which often occurs before significant cardiopulmonary stress and is subject
to confounding factors such as increased body mass and altered gait. Thus, where exercise-induced cardiovascular stress
is desirable, such as in cardiac stress testing or clinical trials, an alternative modality of exercise is required. Cycling will
circumvent several of the associated problems of treadmill walking and may provide an alternative preferable method of
exercise, although there is limited information on the physiologic response of patients with PAD to cycling. This study
compared the peak cardiorespiratory responses and the repeatability of cycling and treadmill exercise in patients with
PAD.
Methods: Ten men (mean age, 54  10 years) with stable IC completed two incremental exercise tests to the limit of
tolerance on a treadmill and a cycle ergometer after familiarization with the outcome measures of exercise duration, work
performed, respiratory gas exchange variables using continuous breath-by-breath measurement, heart rate, and ratings of
perceived pain.
Results: Both methods of exercise assessment revealed high reproducibility in terms of absolute claudication time
(treadmill, r  0.95; cycle, r  0.91), time to volitional fatigue (treadmill, r  0.96; cycle, r  0.91), and
cardiopulmonary exercise responses such as the lactate threshold (treadmill, r  0.95; cycle, r  0.94), peak heart rate
(treadmill, r  0.94; cycle, r  0.96), and peak oxygen uptake (treadmill, r  0.98; cycle, r  0.87). Cycling induced
significantly higher cardiopulmonary responses (peak heart rate, peak carbon dioxide output, peak minute ventilation,
and respiratory exchange ratio) than treadmill exercise. There was no difference in time to volitional fatigue or in absolute
claudication time between exercise modalities.
Conclusion: These results demonstrate that exercise testing using cycling offers an alternative method of cardiopulmonary
testing for patients with IC that is equally reliable and reproducible to treadmill walking. Cycling may be preferable to
treadmill exercise because it induces greater cardiopulmonary and metabolic responses and is better tolerated by patients.
(J Vasc Surg 2008;47:123-30.)Intermittent claudication (IC) is the most common
presentation of peripheral arterial disease (PAD). It is the
symptom of cramping muscle pain brought on by walking
that is felt in the lower limb(s), with subsequent exercise
intolerance, and is relieved by rest. The prevalence in the
middle-aged population in the United Kingdom is 5% and
is expected to rise dramatically due to an increasingly aged
population.1 IC represents the local manifestation of sys-
temic arterial disease that is reflected in a poor life expect-
ancy, with a mortality rate of 20% to 30% at 5 years and 40%
to 72% at 10 years.2 Although IC is the presenting symp-
tom, assessment and treatment of a patient with PADmust
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doi:10.1016/j.jvs.2007.09.001also incorporate evaluation of cardiopulmonary function to
unmask any latent cardiac ischemia. Cardiac stress testing in
this patient population is difficult, however, because walk-
ing exercise tests are limited by peripheral pain rather than
cardiopulmonary function.
Assessment of severity of IC is usually based on patient
self-reporting and quantified by means of ankle-brachial
indices. Treatment for IC most commonly focuses on
conservative therapy, although the number of percutane-
ous transluminal angioplasty procedures has increased ex-
ponentially in recent years despite associated risks and
limited success.3 Initial treatment consisting of a program
of regular dynamic exercise for at least 2 months has limited
financial outlay and has been shown to be as equally effec-
tive as percutaneous transluminal angioplasty.4
Despite several clinical trials reporting that structured
exercise programs result in an improvement in walking
distance in patients with PAD,5,6 the exact mechanism
behind the improvement is unknown. One possibility is
that the improvement in walking distance may reflect direct
effects on the peripheral circulation, but it more likely
represents other cardiopulmonary adaptations to the car-
diopulmonary system.7
123
JOURNAL OF VASCULAR SURGERY
January 2008124 Turner et alClinical trials designed to quantify the success of these
various treatments consistently use treadmill walking as the
modality of outcome analysis.8 As discussed previously,
however, treadmill-walking performance will be limited by
peripheral pain, and thus, any change in cardiopulmonary
function resulting from a treatment programmay bemissed
by this modality of testing. The overwhelming use of
treadmill walking as the preferred method of assessment
may be due to the assumption that treadmill walking sim-
ulates the activities of daily living, but it may also be due to
a lack of research on the physiologic responses of patients
with PAD to other methods of exercise. Treadmill walking
may be subject to confounding factors such as musculoskel-
etal disease and joint problems, cardiopulmonary disease,
gait abnormalities, and increased body mass in addition to
daily changes in the subjective assessment of pain. Indeed,
Barletta et al9 found a poor correlation between treadmill
performance and quality-of-life scores measured using the
McMaster Health Index.
Cycling could potentially circumvent several of these
confounding factors, because unlike treadmill walking, the
saddle bears most the subject’s weight, which minimizes
the impact of increased body mass and altered gate on
exercise performance. Furthermore, the risk of falling dur-
ing cycling exercise is reduced in patients who are extremely
frail. Clinical trials investigating other cardiovascular dis-
eases such as ischemic heart disease have used cycling as the
mainstay of assessing exercise tolerance where walking is
not well tolerated or desirable.10
To date, only one study has compared the cardiopul-
monary responses of patients with IC to cycling and walk-
ing,11 reflecting the difficulties in recruiting a stable ho-
mogenous population of patients with IC in isolation of
other major disease. This study suggested that cycling and
walking exercise induce a similar level of metabolic and
cardiovascular strain. Given the likely unfamiliarity with
cycling exercise, however, it is unknown whether cycling
could provide an appropriate modality of exercise for car-
diac stress testing or indeed a repeatable and quantitative
Table I. Exercise-limiting symptoms, ankle-brachial
index, and preferred mode of exercise by subject
Subjects ABI
Primary exercise-limiting
symptom
PreferenceTreadmill Cycle
1 0.75 Left calf/foot Left calf Cycle
2 0.80 Right calf Right calf Treadmill
3 0.54 Left calf Left calf Cycle
4 0.69 Right calf Right calf Cycle
5 0.64 Left calf Left calf Cycle
6 0.67 Left calf Left calf Cycle
7 0.75 Right calf Right knee Cycle
8 0.80 Left calf Left calf Cycle
9 0.85 Right calf Right calf Treadmill
10 0.71 Right calf Right calf Cycle
ABI, Ankle-brachial index at rest.measure of success for any particular clinical treatmentwhere walking assessment is not possible. The aim of this
study, therefore, was to compare the repeatability of exer-
cise tolerance and maximal cardiopulmonary responses of
treadmill-based exercise with cycle ergometry exercise by
using continuous breath-by-breath measurement for en-
hanced discriminating potential.
METHODS
Subjects. Ten men with IC from whom written in-
formed consent had been obtained were recruited from the
vascular outpatient clinics at Gartnavel General Hospital,
Glasgow, Scotland, to participate in the study. The study
was approved by the North Glasgow NHS Trust Ethics
Committee, and all research was performed in accordance
with the Declaration of Helsinki. Each subject had been
seen several times by a consultant vascular surgeon, had a
history that was in keeping with IC, and had undergone a
clinical examination that supported this. Each had a satis-
factory full medical examination, including an exercise elec-
trocardiogram (ECG), and symptoms that were unchanged
for at least 1 year. In addition, results of static and ambu-
latory ankle-brachial index (ABI) measurements of 0.9
indicated the presence of occlusive arterial disease. Clinical
history and examination indicated that the location of
disease in all subjects was predominately in the superficial
femoral artery division. Their mean age was 52  6 years,
and their mean body mass was 74.6  13.2 kg.
From 20 subjects initially recruited, 4 were excluded
because of other exercise-limiting diseases, 3 had ECG
changes on exercising, and 3 had other uncontrolled dis-
ease. Patients with diabetes mellitus were not included at
the request of the Ethics Committee as a precaution due to
their relatively poorer outlooks compared with nondiabetic
patients.8 The remaining 10 men in the study cohort had
stable claudication. Their medications included antihyper-
tensives in 3, antiplatelet agents in 10, lipid-lowering
agents in 9, and -blockers in 2. All were receiving maximal
medical therapy for atherosclerosis. Eight of the 10 subjects
were ex-cigarette smokers and had ceased smoking 6
months before the study, one continued to smoke, and one
had never smoked.
Experimental design. Subjects were familiarized with
the laboratory procedures and testing methodology on at
least two occasions. After familiarization, each patient com-
pleted two incremental exercise tests to the limit of toler-
ance on a treadmill (T1 and T2) and a cycle (C1 and C2)
ergometer, with at least 6 days separating each test. The
order of initial testing was randomized using computer-
generated allocation, and alternated each week thereafter.
Subjects fasted for 3 hours before all tests and refrained
from alcohol and strenuous exercise for 24 hours before
exercise testing. The ambient temperature of the laboratory
was maintained at 20°C for all exercise tests.
Exercise protocols. Cycling tests were performed us-
ing a ramp-incremental protocol on an electronically
braked computer-controlled cycle ergometer (Excalibur
Sport, Lode, TheNetherlands) to limit of tolerance. After 3
minutes of unloaded cycling (actual work rate equal to 10
T2 an
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pain limited further exercise.12 Symptom-limited time to
volitional fatigue was defined as the point at which the
patient could no longer maintain the pedal cadence above
40 rpm. This time was withheld from the patient until all
exercise tests had been completed.
Treadmill-walking tests were performed on a wide-
bodied motorized treadmill (Woodway PPS55 Med, Weil
am Rhein, Germany) at a speed of 2 km/h at 0% gradient
for 2 minutes, followed by a speed of 3.2 km/h with an
increase in gradient of 0.5% every 30 seconds. Symptom-
limited time to volitional fatigue during treadmill walking
was defined as the point at which subjects could no longer
maintain the preset walking pace.
Perceptual responses. Three time periods were used:
the onset of calf pain (initial claudication time, ICT), the
time to maximal pain (absolute claudication time, ACT),
and time to volitional fatigue (TF). Previously demon-
strated hand signals were used to indicate ICT and ACT.
During the recovery period, subjects were asked to describe
the primary and secondary exercise-limiting symptoms.
Subjects were also required to grade the comparative ease
of cycle compared with treadmill exercise at the end of all
the tests.
Cardiopulmonary gas exchange measures. Gas ex-
change variables were determined breath-by-breath using
algorithms.13 Respiratory volumes were measured with a
bidirectional VMM turbine transducer (Alpha Technolo-
gies, Laguna Niguel, Calif), calibrated with a 3-L syringe,
using a range of different flow profiles (Hans Rudolph,
Kansas City, Mo). Respiratory gas concentrations were
measured every 20 milliseconds by a QP9000 quadruple
mass spectrometer (Morgan Medical, Gillingham, Kent,
UK), which was calibrated against precision-analyzed gas
mixtures. Peak oxygen uptake (V˙O2 peak) was calculated as
the average of the last 15 seconds of the test.
The lactate threshold (L) was estimated noninvasively
as the V˙O2 at which (1) the break-point in the relationship
between carbon dioxide (CO2) output (V˙CO2) and V˙O2
Table II. Exercise tolerance and cardiopulmonary respons
Variables
Treadmill test
1
TF (min) 10.0  4.7
ACT (min) 9.1  5.3
ICT (min) 3.4  0.8
V˙O2 peak (L/min) 1.27  0.44
V˙O2 at L (L/min)* 1.03  0.20
V˙CO2 peak (L/min) 1.08  0.41
V˙E peak (L/min) 41.6  18.2
HR peak (beats/min) 128  29
RER peak 0.84  0.09
TF, Time to volitional fatigue;ACT, absolute claudication time; ICT, initial
output; V˙E, minute ventilation; HR, heart rate; RER, respiratory exchange
*N  9 because L was impossible to identify.
†Represents a significant difference between the two modes of exercise (ie,(“V-slope” technique) occurred and (2) the ventilatoryequivalent for O2 (V˙E/V˙O2) and end-tidal PO2 started to
increase systematically without a concomitant increase in
the ventilatory equivalent for CO2 (V˙E/V˙CO2) and a fall
in the end-tidal PCO2 . 
14 Heart rate was derived beat-to-
beat from the R-R interval of a 12-lead ECG (Quinton
Medical, Manchester, UK).
Data analysis. Mean and standard deviation (SD)
were calculated for each variable. The Pearson product
moment correlation coefficient (r) was used to compare
exercise tests. The limits of agreement (LOA) between the
first and second exercise tests were investigated by plotting
the individual between-day differences against their respec-
tive means (Bland-Altman plots).15 Heteroscedasticity was
examined by plotting the absolute (positive) differences
against the individual means and calculating the correlation
coefficient.16 If the heteroscedasticity correlation was close
to zero and the differences were normally distributed
(Shapiro-Wilks test), the mean bias and 95% LOA were
calculated as mean  1.96 SD of the between method
difference.17 Paired t tests were used to compare the mea-
surements obtained from treadmill and cycle tests. All data
were analyzed using SPSS 11.0 software (SPSS Inc, Chi-
cago, Ill). Significance was set a priori at P  .05.
RESULTS
Exercise tolerance. All subjects were primarily limited
by calf pain (Table I). Several subjects reported secondary
limiting symptoms of pain in other areas. A summary of the
cardiopulmonary responses for treadmill and cycling exer-
cise is presented in Table II for group responses and in Figs
1 and 2 for individual responses. No significant differences
were found in TF within or between modes of exercise
(Table II, Fig 1). TF on the two treadmill tests (r  0.96;
P .001) and the two cycle tests (r 0.91; P .001) were
highly correlated. TF was also significantly correlated be-
tween modes of exercise but only on the second test (T1 vs
C1, r 0.53, P .115 and T2 vs C2, r 0.65, P .042).
Bland-Altman plots for TF for within and between modes
ring treadmill and cycling exercise.
Cycle test
2 1 2
 5.0 9.3  2.4 9.5  2.5
 5.4 8.7  2.3 8.9  2.6
 1.5 5.1  2.1 4.7  1
 0.36 1.35  0.29 1.39  0.30
 0.23 0.92  0.13 0.92  0.12
 0.35† 1.31  0.32 1.35  0.31†
 16.5† 54.2  16.5 55.2  16.1†
 31† 140  30 140  25†
 0.08† 0.96  0.1 0.96  0.07†
cation time; V˙O2, oxygen uptake; L, lactate threshold; V˙CO2, carbon dioxide
d C2).es du
10.6
10.2
4.3
1.28
1.03
1.09
41.8
126
0.84
claudi
ratio.of exercise are shown in Fig 3.
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during the second cycle test (6.0  1.4 minutes) compared
with all others exercise tests (T1, 3.30.8minutes; T2, 5.0
3.3 minutes; C1, 4.1  1.4 minutes; Fig 1, Table II). ICT was
not correlatedwithin the twomodes of exercise (T1 vsT2: r
0.620, P  .189; C1 vs C2: r  0.124, P  .770) or
between modes of exercise (T1 vs C1: r0.473, P .421;
T2 vs C2: r 0.026, P  .951). ACT was not different
either within or between modes of exercise (Table II, Fig 1)
and was significantly correlated both within the twomodes of
exercise (T1 vs T2: r 0.95, P .001; C1 vs C2: r 0.91, P
 .001) and between modes of exercise (T1 vs C1: r 0.69,
P .027; T2 vs C2: r 0.77, P .207). Bland-Altman plots
for ACT for within and between modes of exercise are pre-
sented in Fig 4. Eight of 10 subjects preferred the cycle test
when asked to rate their preference, although the pain of IC
Fig 1. Time to volitional fatigue (TF), absolute claudication time
(ACT), and initial claudication time (ICT) by exercise mode and
subject.limited all exercise tests (Table I).Cardiopulmonary responses. Although none of the
peak cardiopulmonary responses differed significantly within
the two modes of exercise (Table II, Fig 2), a number of these
responses were significantly higher during cycling compared
with treadmill exercise: V˙CO2 (T1 vs C1, P .049; T2 vs C2,
P  .04), V˙E (T1 vs C1, P  .004; T2 vs C2, P  .001),
respiratory exchange ratio (RER; T1 vs C1, P  .001; T2 vs
C2, P .001), and heart rate (T1 vs C1, P .017; T2 vs C2,
P .004). Peak V˙O2 tended to be higher during cycling, but
this difference did not reach statistical significance (T1 vs C1,
P  .345; T2 vs C2, P  .087; Table II, Fig 2). Peak
cardiopulmonary responses were highly correlated both
within the two modes of exercise and between modes of
exercise (Table III).
Oxygen uptake at the L was not significantly differ-
Fig 2. Peak oxygen uptake (V˙O2peak), peak heart rate, and oxy-
gen uptake (V˙O2) at lactate threshold (L) by test and exercise
mode. Results from individual patients and the group mean are
presented for each exercise test.ent either within (T1 vs T2, P  .82; C1 vs C2, P  .96)
Fig 3. Bland-Altman plot of time to volitional fatigue (TF).
Fig 4. Bland-Altman plot of absolute claudication time (ACT).
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Volume 47, Number 1 Turner et al 127or between (T1 vs C1, P  .215; T2 vs C2, P  .207) the
two modes of exercise (Table II, Fig 3). The V˙ O2 at the
L for the two treadmill tests and the two cycle tests were
highly correlated and did not correlate between the two
modes of exercise (Table III). Bland-Altman plots for
V˙ O2 PEAK, peak heart rate, and V˙ O 2 at the L for both
within and between modes of exercise are presented in
Figs 5 to 7, respectively.
Discussion
The primary finding of this comparative study of stable
men with IC is that using cycling for exercise testing yields
information comparable with treadmill exercise, whether
measured by traditional subjective measures of pain-limited
exercise tolerance or other more objective physiologic perfor-
mance outcome measures such as V˙ O2, V˙ CO2, V˙ E, RER, heart
rate, and L. To our knowledge, however, this study is the first
to show that exercise testing using cycle ergometry incurred a
significantly higher cardiovascular and metabolic response
than treadmill walking and, paradoxically, was better tolerated
by subjects. This may be particularly relevant where the aim is
to stress the cardiopulmonary system in patients with IC
rather than peripheral musculature, such as during a cardiac
stress test or when cardiopulmonary function is assessed be-
fore and after a treatment program.
Previous studies of claudication have used a number of
subjective outcome measures, for example, ICT, ACT, and
TF. However, many factors can influence the subjective
assessment of pain and physical performance with conse-
quent potential increased variability and unreliability. This
is reflected in some studies of treadmill-based exercise
testing that report coefficients of variation of 15% to 40%
for claudication distance and maximal walking dis-
tance.12,16-18 ICT would appear to be a less reliable mea-
sure of walking ability than ACT.19-21 The results of the
present study support this and suggest that ACT and TF are
Table III. Predicted* maximum oxygen consumption vs
measured peak oxygen consumption on treadmill and
cycle.
Subject Predicted* Treadmill Cycle
1 2.32 1.42 1.46
2 2.30 1.40 1.26
3 2.38 0.89 1.18
4 2.06 1.22 1.29
5 1.92 0.74 0.91
6 2.40 1.10 1.41
7 2.20 1.45 1.32
8 2.38 1.54 1.84
9 2.36 2.01 1.94
10 1.92 1.07 1.32
Mean (SD) 2.22 1.28† 1.39†
(0.19) (0.36) (0.30)
*Maximum oxygen consumption predicted on basis of age, sex, height, and
weight.
†Represents a significant difference from predicted maximum oxygen con-
sumption,Treadmill
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Fig 5. Bland-Altman plot of peak oxygen uptake (V˙O2 peak).
Fig 6. Bland-Altman plot of peak heart rate.
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mance outcome measures (ie, V˙O2, V˙CO2, V˙E, RER, heart
rate, and L) did not rely on subjective assessment or
volition and reflect whole-body performance rather than
peripheral muscle limitation in isolation. The measure-
ments that reflect the maximum rates of oxygen consump-
tion (V˙O2), carbon dioxide production (V˙O2), and minute
ventilation (V˙E PEAK) provide a measure of aerobic capacity
and physical fitness. Conversely, L is the exercise intensity
at which lactate starts to accumulate in the blood stream
and is an indicator of anaerobic fitness.
Given the severe physiologic deconditioning of patients
with PAD, these indicators would be expected to increase
significantly after a clinical intervention and thus would
provide a useful outcome measure of the relative success or
failure of the treatment. These additional indicators are not
subject to the same degree of subjectivity and variability as
the traditional perceptual performance outcome measures
andmay provide useful measures with better discriminating
power in the assessment of cardiopulmonary performance
in patients with IC before and after an exercise treatment
program. This is reflected in the exclusion of three of the 20
patients initially recruited who were found to be clinically
free of ischemic heart disease on the basis of cycle-induced
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mination of the L in all but one patient (Table II). It is well
acknowledged that the determination of the L is difficult,
even by experienced investigators, when the exercise dura-
tion is short, as is the case in this patient group. Rates of
V˙O2 at the L were not different either within or between
the two modes of exercise and were highly correlated
within modes of exercise but not between modes of exer-
cise (Table II, Fig 3). The L as a measure of muscle
bioenergetics has been applied with considerable success in
a variety of conditions characteristic of moderate to severe
exercise intolerance such as chronic obstructive pulmonary
disease (COPD)22,23 and heart failure.24 It also has practi-
cal applications and has been used to stratify preoperative
cardiac risk.25 In the population of patients with PAD in
whom operative treatment is required, L ascertained using
cycling exercise testing might provide a valuable method of
operative risk stratification.
To our knowledge, this study is the first to show that
despite both modes of exercise inducing similar and predict-
able exercise intolerance—the subjective assessment of pain,
the work performed and, more important, the determination
of the L were very closely matched between modes of exer-
cise—several peak cardiopulmonary responses other than V˙O2
were higher during cycling compared with treadmill exercise
(ie, V˙CO2, V˙E, heart rate, and RER). This observation differs
from previous studies of healthy adults, athletes, and other
subject groupswho report a highermetabolic response during
treadmill exercise26,27 and a V˙ O2MAX up to 7% higher than
cycle exercise.28
The finding of a greater cardiopulmonary and metabolic
response during cycling exercise in patients with IC in the
present study is in agreement with an analogous study com-
paring cycle and treadmill exercise in patients with severe
COPD.23 These authors found that although peak V˙ O2 did
not differ between the two forms of exercise, postexercise
blood lactate levels were substantially higher after cycle exer-
cise than after treadmill exercise (ie, 2.5 vs 1.22 mmol/L).
This was attributed to differences in the rates of lactate forma-
tion and clearance due to “unfamiliarity” of cycling exercise in
patients with COPD.23 These results suggest that cycle exer-
cise may be a more appropriate method of exercise testing in
patients with PADwhere the aim is to stress the cardiovascular
system, such as in cardiac stress testing to unmask any latent
cardiac ischemia or when testing the efficacy of a particular
treatment program.
The peak cardiopulmonary responses during both tread-
mill walking and cycling in the present group of patients with
IC were significantly lower than predicted for patients’ age
and sex, likely due to severe physiologic deconditioning (Ta-
ble III). This reduced exercise tolerance is in agreement with
previous studies that found lower peak responses in patients
with PAD compared with healthy controls29 and most likely
reflects the fact that exercise tolerance in this patient group is
limited primarily by peripheral rather than central factors. 30
The greater cardiopulmonary and metabolic strain in the
absence of a significantly higher V˙O2 during cycling exercise
may reflect an increased and more localized recruitment ofmore proximal and better-perfused muscles during cycling.
Although bothmodalities were equally well tolerated in terms
of similar exercise duration and intensity, they appear to be
testing the cardiopulmonary systems to differing degrees.
Eight of the 10 patients preferred the cycle ergometer test
(Table I) even though the pain felt and the work performed
was similar between the two methods of testing. One of the
two patients who preferred the treadmill test reported thigh
and knee pain in addition to calf pain during cycling, whereas
hip and back pain were more prevalent during treadmill walk-
ing. Cycling may therefore be the preferred mode of exercise
when greater systemic responses are desired either as a thera-
peutic measure (exercise training) or as a method of revealing
underlying cardiopulmonary compromise that would other-
wise be latent.
The present study is not without its limitations. A select
group of patients were studied; therefore, extrapolating these
findings to amore generalized populationwith ICmay not be
possible. Although ischemic pain from claudicationmayman-
ifest in the thigh and buttocks, exercise performance in the
present study was primarily limited by calf pain (Table I).
Patients with ischemic pain in different locations may not
necessarily respond in the same manner to the different exer-
cise modalities as those in the present study. Strict entry
criteria were chosen to create a homogenous population in
terms of symptoms and cardiopulmonary and metabolic re-
sponses without other disease that could confound the results
and thus ensure a greater power to detect differences in
cardiopulmonary responses. This study would require verifi-
cation in a larger number of patientswith greater severity of IC
before its practical application to either replace treadmill test-
ing or perhaps more interestingly, compare the relative bene-
fits of different modes of exercise training.
Conclusion
This study has shown that cardiopulmonary exercise
testing involving cycling exercise offers an alternative mode
of testing for patients with IC that is equally reliable and
reproducible to treadmill exercise. Of greater interest is the
novel finding of this study that cycling exercise can induce
greater cardiopulmonary and metabolic responses and in
general is more acceptable to these patients compared with
treadmill exercise. Cycle exercise may therefore be the
preferred mode of exercise for testing before and after a
treatment program in a clinical trial or during a cardiac
stress test when the aim is to stress the general cardiovas-
cular system. In addition, clinicians and researchers may
prefer the use of cycling as the modality of exercise testing
in patients with IC because it is non-weight-bearing and
minimizes the risk of falling in frail patients. The potential
benefits of using cycle exercise as a method of treatment for
patients with IC is out with the remit of the present study.
The cooperation of all patients is greatly appreciated.
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